Dr. POON Chiu Yee, Liona
Current Position:
Professor (Clinical)
Office Phone:
(852) 3505 1290
Email:
liona.poon@cuhk.edu.hk
Biographical details
Liona Poon was awarded MBBS from University of London in 2002 and undertook her specialty training in Obstetrics and Gynaecology in London. She gained a 3-year training fellowship from the Fetal Medicine Foundation and during this time, established a major screening programme for early detection of preeclampsia, which led to a Doctorate of Medicine (Research) in 2011. She then undertook subspecialty training in maternal fetal medicine at Imperial College Healthcare NHS Trust and King’s College Hospital NHS Foundation Trust with Mr TG Teoh and Professor KH Nicolaides as supervisors.
Qualifications:
MBBS (University of London), MRCOG, MD(Res) (University of London), Cert RCOG (Maternal and Fetal Medicine)
Research interests:
Her main research interests are in the prediction and prevention of maternal and perinatal morbidity and mortality. These include developing screening models for the prediction of aneuploidies, preeclampsia, fetal growth restriction, gestational diabetes, macrosomia, stillbirth, spontaneous preterm birth and induced labour. She is currently conducting a pan-European multicentre randomised controlled trial of Aspirin vs. placebo in the prevention of preterm preeclampsia (ASPRE), which is funded by the EC FP7 scheme. She has authored over 100 peer-reviewed publications in the top quartile of international journals in the field of Obstetrics and Gynaecology and Hypertension.
Grants:
EC FP7 (601852-2), NIHR EME (14/01/02), NIHR HTA (14/158), CUHK Start-up Support Fund, HK O&G Trust Fund
| 1 | Clinical Opinion: The diagnosis and management of suspected fetal growth restriction: an evidence-based approach Lees CC, Romero R, Stampalija T, Dall'Asta A, DeVore GA, Prefumo F, Frusca T, Visser GHA, Hobbins JC, Baschat AA, Bilardo CM, Galan HL, Campbell S, Maulik D, Figueras F, Lee W, Unterscheider J, Valensise H, Da Silva Costa F, Salomon LJ, Poon LC, Ferrazzi E, Mari G, Rizzo G, Kingdom JC, Kiserud T, Hecher K Am J Obstet Gynecol. 2022 Mar;226(3):366-378 |
| 2 | The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, Kenny LC, McCarthy F, Myers J, Poon LC, Rana S, Saito S, Staff AC, Tsigas E, von Dadelszen P Pregnancy Hypertens. 2022 Mar;27:148-169 |
| 3 | Prelabor short-term variability in fetal heart rate by computerized cardiotocogram and maternal fetal Doppler indices for the prediction of labor outcomes Lam MSN, Chaemsaithong P, Kwan AHW, Wong STK, Tse AWT, Sahota DS, Leung TY, Poon LC J Matern Fetal Neonatal Med. 2022 Apr;35(7):1318-1327 |
| 4 | The use of ultrasound, fibronectin and other parameters to predict the success of labour induction Lau SL, Kwan A, Tse WT, Poon LC Best Pract Res Clin Obstet Gynaecol. 2022 Mar;79:27-41 |
| 5 | First trimester preeclampsia screening and prediction Chaemsaithong P, Sahota D, Poon LC Am J Obstet Gynecol. 2022 Feb;226(2S):S1071-S1097.e2. |
| 6 | Prevention of preeclampsia with aspirin Rolnik DL., Nicolaides KH, Poon LC Am J Obstet Gynecol. 2022 Feb;226(2S):S1108-S1119 |
| 7 | Increased levels of soluble fms-like tyrosine kinase-1 are associated with adverse outcomes in pregnant women with COVID-19 Torres-Torres J, Espino-Y-Sosa S, Poon LC, Solis-Paredes JM, Estrada-Gutierrez G, Espejel-Nuñez A, Juarez-Reyes A, Etchegaray-Solana A, Alfonso-Guillen Y, Aguilar-Andrade L, Hernández-Pacheco JA, Villafan-Bernal JR, Martinez-Portilla RJ Ultrasound Obstet Gynecol. 2022 Feb;59(2):202-208 |
| 8 | Prospective Evaluation of International Prediction of Pregnancy Complications Collaborative Network Models for Prediction of Preeclampsia: Role of Serum sFlt-1 at 11Â13 Weeks Gestation Chaiyasit N, Sahota DS, Ma R, Choolani M, Wataganara T, Sim WS, Chaemsaithong P, Wah YMI, Hui ASY, Poon LC Hypertension. 2022 Feb;79(2):314-322 |
| 9 | Comorbidity, poverty and social vulnerability as risk factors for mortality in pregnant women with confirmed SARS-CoV-2 infection: analysis of 13 062 positive pregnancies including 176 maternal deaths in Mexico Torres-Torres J, Martinez-Portilla RJ, Espino-Y-Sosa S, Estrada-Gutierrez G, Solis-Paredes JM, Villafan-Bernal JR, Medina-Jimenez V, Rodriguez-Morales AJ, Rojas-Zepeda L, Poon LC Ultrasound Obstet Gynecol. 2022 Jan;59(1):76-82 |
| 10 | Perspectives on administration of COVID-19 vaccine to pregnant and lactating women: a challenge for low- and middle-income countries Duarte G, Coutinho CM, Rolnik DL, Quintana SM, Rabelo E Silva AC, Poon LC, Costa FDS AJOG Glob Rep. 2021 Nov;1(4):100020 |
| 11 | Single-molecule sequencing reveals a large population of long cell-free DNA molecules in maternal plasma Yu SCY, Jiang P, Peng W, Cheng SH, Cheung YTT, Tse OYO, Shang H, Poon LC, Leung TY, Chan KCA, Chiu RWK, Lo YMD Proc Natl Acad Sci U S A. 2021 Dec 14;118(50):e2114937118 |
| 12 | Evidence of possible SARS-CoV-2 vertical transmission according to World Health Organization criteria in asymptomatic pregnant women Sevilla-Montoya R, Hidalgo-Bravo A, Estrada-Gutiérrez G, Villavicencio-Carrisoza O, Gonzalez-GarcÃÂa LD, Leon-Juarez M, Mora-Vargas CD, Villegas-Mota I, Espino-y-Sosa S, Mateu-Rogell P, Rodriguez-Bosch M, Monroy-Muñoz IE, Coronado-Zarco I, Acevedo-Gallegos S, Aguinaga-RÃÂos M, Ramirez-Santes VH, Ortiz-Ramirez MA, Valdes-Flores M, Cortes-Bonilla M, MartÃÂnez-Portilla R, Poon LC, Cardona-Pérez JA, Helguera-Repetto AC Ultrasound Obstet Gynecol. 2021 Dec;58(6):900-908 |
| 13 | ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis Shen L, Martinez-Portilla RJ, Rolnik DL, Poon LC Ultrasound Obstet Gynecol. 2021 Oct;58(4):546-552 |
| 14 | Incidence of pre-eclampsia and other perinatal complications among pregnant women with congenital heart disease: systematic review and meta-analysis Martinez-Portilla RJ, Poon LC, Benitez-Quintanilla L, Sotiriadis A, Lopez M, Lip-Sosa DL, Figueras F Ultrasound Obstet Gynecol. 2021 Oct;58(4):519-528 |
| 15 | Transperineal ultrasound assessment of fetal head elevationby maneuvers used for managing umbilical cord prolapse Kwan AHW, Chaemsaithong P, Wong L, Tse WT, Hui ASY, Poon LC, Leung TY Ultrasound Obstet Gynecol. 2021 Oct;58(4):603-608 ÃÂÃÂ ÃÂÃÂ |
| 16 | How Different Are Diverse Populations in Screening for Preeclampsia? Martinez-Portilla RJ, Poon LC Maternal-Fetal Medicine. 2021 Apr; 3(2):87-90 |
| 17 | First Trimester Screening for Preeclampsia: An Asian Perspective Moungmaithong S, Wang XQ, Tai AST, Feng QL, Sahota D, Leung TY, Poon LC Maternal-Fetal Medicine. 2021 Apr; 3(2):116-12 |
| 18 | Effective aspirin treatment of women at risk for preeclampsia delays the metabolic clock of gestation Li X, Milosavljevic A, Elsea SH, Wang CC, Scaglia F, Syngelaki A, Nicolaides KH, Poon LC Hypertension. 2021 Nov;78(5):1398-1410 |
| 19 | Novel ratio soluble fms-like tyrosine kinase-1/Angiotensin-II (sFlt-1/ANG-II) in pregnant women is associated with critical illness in COVID-19 Espino-y-Sosa S, Martinez-Portilla RJ, Torres-Torres J, Mario Solis, Paredes J, Estrada-Gutierrez G, Hernandez-Pacheco AN, Espejel-NuÃÂñez A, Mateu-Rogell P, Juarez-Reyes A, Lopez-Ceh FE, Villafan-Bernal JR, Rojas-Zepeda L, Guzman-Guzman IP, Poon LC Viruses 2021 Oct; 13(10): 1906 |
| 20 | A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia Compiled by the Pregnancy and Non-Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics) Poon LC, Magee LA, Verlohren S, Shennan A, von Dadelszen P, Sheiner E, Hadar E, Visser G, Costa FD, Kapur A, McAuliffe F, Nazareth A, Tahlak M, Kihara AB, Divakar H, McIntyre HD, Berghella V, Yang HX, Romero R, Nicolaides KH, Melamed N, Hod M Int J Gynaecol Obstet. 2021 Jul;154 Suppl 1:3-31 |
| 21 | Outcome of radiofrequency ablation for selective fetal reduction before vs at or after 16 gestational weeks in complicated monochorionic pregnancy Ting YH, Poon LCY, Tse WT, Chung MY, Wah YM, Hui ASY, Law KM, Chaemsaithong P, Leung TY Ultrasound Obstet Gynecol. 2021 Aug;58(2):214-220 |
| 22 | Impact of replacing or adding placental growth factor on Down syndrome screening: A prospective cohort study Sin AWT, Poon LC, Chaemsaithong P, Wah IYM, Hui ASY, Ting YH, Law KM, Leung TY, Sahota DS Prenat Diagn. 2021 Aug;41(9):1111-1117 |
| 23 | Bronchopulmonary sequestration treated successfully with prenatal radiofrequency ablation of feeding artery Tse WT, Poon LC, Wah YM, Hui ASY, Ting YH, Leung TY Ultrasound Obstet Gynecol. 2021 Aug;58(2):325-327 |
| 24 | Pregnancy and neonatal outcomes in COVID-19: study protocol for a global registry of women with suspected or confirmed SARS-CoV-2 infection in pregnancy and their neonates, understanding natural history to guide treatment and prevention Banerjee J, Mullins E, Townson J, Playle R, Shaw C, Kirby N, Munnery K, Bourne T, Teoh TG, Dhanjal M, Poon L, Wright A, Lees C BMJ Open. 2021 Jan 29;11(1):e041247 |
| 25 | Young pregnant women are also at an increased risk of mortality and severe illness due to coronavirus disease 2019: Analysis of the Mexican National Surveillance Program Martinez Portilla RJ, Smith ER, He S, Torres JT, Espino-Y-Sosa S, Solis-Paredes JM, Poon LC Am J Obstet Gynecol. 2021 Apr;224(4):404-407 |
| 26 | Preeclampsia: Universal Screening or Universal Prevention for Low and Middle-Income Settings? Rolnik DL, Carvalho MHB, Lobo GAR, Verlohren S, Poon L, Baschat A, Hyett J, Thilaganathan B, Bujold E, Costa FDS Rev Bras Ginecol Obstet. 2021 Apr;43(4):334-338 |
| 27 | The Use of Somatex Shunt for Fetal Pleural Effusion: A Cohort of 8 Procedures Chung MY, Leung WC, Tse WT, Ting YH, Law KM, Hui ASY, Wah YM, Lam HS, Poon LCY, Leung TY Fetal Diagn Ther. 2021;48(6):440-447 |
| 28 | Update on diagnosis of hyperglycemia in pregnancy and gestational diabetes mellitus from FIGOâÃÂÃÂs Pregnancy & Non- Communicable Diseases Committee Poon LC, Hod M, McIntyre HD, Oats JJN, Kihara AB, Divakar H, Kapur A Int J Gynaecol Obstet. 2021 Aug;154(2):189-194 |
| 29 | Cost-utility of a first-trimester screening strategy versus the standard of care for nulliparous women to prevent preterm preeclampsia in Belgium Dubon Garcia A, Devlieger R, Redekop K, Vandeweyer K, Verlohren S, Poon LC Pregnancy Hypertens. 2021 Jul 1;25:219-224 |
| 30 | Application of an individualized nomogram in first-trimester screening for trisomy 21 Sun Y, Zhang L, Dong D, Li X, Wang J, Yin C, Poon LC, Tian J, Wu Q Ultrasound Obstet Gynecol. 2021 Jul;58(1):56-66 |
| 31 | Prediction of spontaneous preterm birth by cervical length in the first trimester of pregnancy: comparison of two measurement methods Feng Q, Duan H, Ju X, Appiah K, Yip KM, Tai Y, Sun Q, Chaemsaithong P, Poon LC Acta Obstet Gynecol Scand. 2021 Jul;100(7):1305-1312 |
| 32 | Accuracy of the FMF Bayes theorem-based model for predicting preeclampsia at 11-13 weeks of gestation in a Japanese population Goto M, Koide K, Tokunaka M, Takita H, Hamada S, Nakamura M, Matsuoka Ryu, Sekizawa A, Poon LC Hypertens Res. 2021 Jun;44(6):685-691 |
| 33 | Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies Poon LC, Leung BW, Ma T, Yu FN, Kong CW, Lo TK, So PL, Leung WC, Shu W, Cheung KW, Moungmaithong S, Wang CC Ultrasound Obstet Gynecol. 2021 Jun;57(6):974-978 |
| 34 | Equity in coronavirus disease 2019 vaccine development and deployment Modi N, Ayres-de-Campos D, Bancalari E, Benders M, Briana D, Di Renzo GC, Fonseca EB, Hod M, Poon L, Cortes MS, Simeoni U, Tscherning C, Vento M, Visser GHA, Voto L Am J Obstet Gynecol. 2021 May;224(5):423-427 |
| 35 | Doppler-based predictive model for methotrexate resistancein low-risk gestational trophoblastic neoplasia withmyometrial invasion: prospective study of 147 patients Qin J, Zhang S, Poon L, Pan Z, Luo J, Yu N, Wang L, Wu X, Cheng X, Xie X, Lu Y, Lu W Ultrasound Obstet Gynecol. 2021 May;57(5):829-839 |
| 36 | FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction Melamed N, Baschat A, Yinon Y, Athanasiadis A, Mecacci F, Figueras F, Berghella V, Nazareth A, Tahlak M, McIntyre HD, Costa FD, Kihara AB, Hadar E, McAuliffe F, Hanson M, Ma RC, Gooden R, Sheiner E, Kapur A, Divakar H, Ayres-de-Campos D, Hiersch L, Poon LC, Kingdom J, Romero R, Hod M Int J Gynaecol Obstet. 2021 Mar;152 Suppl 1:3-57 |
| 37 | Genome-wide detection of cytosine methylation by single molecule real-time sequencing Tse OYO, Jiang P, Cheng SH, Peng W, Shang H, Wong J, Chan SL, Poon LCY, Leung TY, Chan KCA, Chiu RWK, Lo YMD Proc Natl Acad Sci U S A. 2021 Feb 2;118(5):e2019768118 |
| 38 | Omics and perinatal medicine Preeclampsia Chaemsaithong P, Poon LC In:ÃÂÃÂ New Technologies and Perinatal Medicine: Prediction and Prevention of Pregnancy Complications CRC Press, 2019 Dec, Ch25 |
| 39 | Scientific effort in combating COVIDâÃÂÃÂ19 in obstetrics and gynecology Martinez-Portilla RJ, Gil MM, Poon LC Ultrasound Obstet Gynecol. 2021 Feb;57(2):189-194 |
| 40 | Pregnant women with SARS-CoV-2 infection are at higher risk of death and pneumonia: propensity score-matched analysis of a nationwide prospective cohort study (COV19Mx) MartinezâÃÂÃÂPortilla RJ, Sotiriadis A, Chatzakis C, TorresâÃÂÃÂTorres J, Espino Y Sosa S, SandovalâÃÂÃÂMandujano K, CastroâÃÂÃÂBernabe DA, MedinaâÃÂÃÂJimenez V, MonarrezâÃÂÃÂMartin JC, Figueras F, Poon LC Ultrasound Obstet Gynecol. 2021 Feb;57(2):224-231 |
| 41 | Single-cell RNA expression profiling of SARS-CoV-2-related ACE2 and TMPRSS2 in human trophectoderm and placenta Cui D, Liu Y, Jiang X, Ding C, Poon LC, Wang H, Yang H Ultrasound Obstet Gynecol. 2021 Feb;57(2):248-256 |
| 42 | Comparison of uterine artery Doppler measurements at 6 weeks of pregnancy after IVF between pregnancies that resulted in miscarriage and ongoing pregnancies Guo J, Chaemsaithong P, Huang J, Chung JPW, Huang J, Poon LCY, Li TC Int J Gynaecol Obstet. 2021 Feb;152(2):249-255 |
| 43 | The significance of low first trimester serum progesterone in ongoing early pregnancies presenting as pregnancies of unknown location Ucyigit A, Fuller JL, Poon LC, J Johns, Ross JA Eur J Obstet Gynecol Reprod Biol. 2021 Jan 12;258:294-298 |
| 44 | ISUOG Safety Committee Position Statement: safe performance of obstetric and gynecological scans and equipment cleaning in the context of COVID-19 (opinion) Poon LC, Abramowicz JS, Dall'Asta A, Sande R, Ter Haar G, Maràáal K, Brezinka C, Miloro P, Basseal J, Westerway SC, Abu-Rustum RS, Lees C Ultrasound Obstet Gynecol. 2020 May,55(5):709-712 |
| 45 | Does Low-Dose Aspirin Initiated Before 11 Weeks' Gestation Reduce the Rate of Preeclampsia? (COMMENT) Chaemsaithong P, Cuenca-Gomez D, Plana MN, Gil MM, Poon LC Obstetrical & Gynecological Survey. 2020 Oct ;75(10):581-582 |
| 46 | Bradycardia-to-delivery interval and fetal outcomes in umbilical cord prolapse Wong L,ÃÂÃÂ Tse WT,ÃÂÃÂ Lai CY,ÃÂÃÂ Hui ASY,ÃÂÃÂ Chaemsaithong P, Sahota DS,ÃÂÃÂ PoonÃÂÃÂ LC,ÃÂÃÂ Leung TY Acta Obstet Gynecol Scand. 2021 Jan;100(1):170-177 |
| 47 | Feasibility, Reliability and Agreement of Transperineal Ultrasound Measurement: Result from a Longitudinal Cohort Study Kwan AHW, Chaemsaithong P, Tse WT, Appiah K, Chong KC, Leung TY, Poon LC Fetal Diagn Ther 2020 Oct;47(10):721âÃÂÃÂ730 |
| 48 | Monochorionic twins with selective fetal growth restriction: insight from placental whole transcriptome analysis LI W, Chung CYL, Wang CC, Chan TF, Leung MBW, Chan OK, Wu L, APPIAH K, Chaemsaithong P, Cheng YKY, Poon LCY, Leung TY Am J Obstet Gynecol. 2020 Nov;223(5):749.e1-749.e16 |
| 49 | Shear-wave sonoelastographic assessment of cervix in pregnancy Duan H, Chaemsaithong P, Ju X, Ho SYS, Sun Q, Tai Y, Leung TY, Poon LC Acta Obstet Gynecol Scand. 2020 Nov;99(11):1458-1468ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ |
| 50 | Risk factors for anxiety and depression among pregnant women during the COVID-19 pandemic A web-based cross-sectional survey Kajdy A, Feduniw S, Ajdacka U, Modzelewski J, Baranowska B, Sys D, Pokropek A, Pawlicka P, Kazmierczak M, Rabijewski M, Jasiak H, Lewandowska R, Borowski D, Kwiatkowski S, Poon LCÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ Medicine (Baltimore). 2020 Jul 24;99(30):e21279ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ |
| 51 | Detection and characterization of jagged ends of double-stranded DNA in plasma Jiang P, Xie T, Ding SC, Zhou Z, Cheng SH, Chan RWY, Lee WS, Peng W, Wong J, Wong VWS, Chan HL, Chan SL, Poon LC, Leung TY, Chan AKC, Chiu RWK, Lo DYM Genome Res. 2020 Aug;30(8):1144-1153ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ |
| 52 | ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction Lees CC, Stampalija T, Baschat A, da Silva Costa F, Ferrazzi E, Figueras F, Hecher K, Kingdom J, Poon LC, Salomon LJ, Unterscheider JÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ Ultrasound Obstet Gynecol. 2020 Aug;56(2):298-312ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ |
| 53 | First-trimester pre-eclampsia biomarker profiles in Asian population: a multicenter cohort study Chaemsaithong P, Sahota D, Pooh RK, Zheng M, Ma R, Chaiyasit N, Koide K, Shaw SW, Seshadri S, Choolani M, Panchalee T, Yapan P, Sim WS, Sekizawa A, Hu Y, Shiozaki A, Saito S, Leung TY, Poon LC Ultrasound Obstet Gynecol. 2020 Aug;56(2):206-214 |
| 54 | The effect of race on longitudinal maternal central hemodynamics Ling HZ, Garcia Jara P, Bisquera A, Poon LC, Nicolaides K, Kametas NA Ultrasound Obstet Gynecol. 2020 Jul;56(1):37-43ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ |
| 55 | Effects of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcomes: a systematic review Juan J, Gil MM, Rong Z, Zhang Y, Yang H, Poon LCÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ Ultrasound Obstet Gynecol. 2020 Jul;56(1):15-27 |
| 56 | ISUOG Interim Guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium: information for healthcare professionals - an update (INTERIM GUIDANCE) Poon LC, Yang H, Dumont S, Lee JCS, Copel JA, Danneels L, Wright A, Costa FD, Leung TY, Zhang Y, Chen D, Prefumo F Ultrasound Obstet Gynecol. 2020 Jun;55(6):848-862 |
| 57 | Maternal cardiac function in women at high-risk for pre-eclampsia treated with 150 mg aspirin or placebo: an observational study Ling HZ, Jara PG, Bisquera A, Poon LC, Nicolaides KH, Kametas NA BJOG. 2020 Jul;127(8):1018-1025 |
| 58 | ISUOG Safety Committee Position Statement on use of personal protective equipment and hazard mitigation in relation to SARS-CoV-2 for practitioners undertaking obstetric and gynecological ultrasound (opinion) Abramowicz JS, Basseal JM, Brezinka C, Dall'Asta A, Deng J, Harrison G, Lee JCS, Lim A, Maràáal K, Miloro P, Poon LC, Salvesen KÃÂà, Sande R, Ter Haar G, Westerway SC, Xie MX, Lees C Ultrasound Obstet Gynecol. 2020 Jun;55(6):886-891 |
| 59 | Intrauterine vertical transmission of SARS-CoV-2: what we know so far (opinion) Wang C, Zhou YH, Yang HX, Poon LCÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ Ultrasound Obstet Gynecol. 2020 Jun;55(6):724-725 |
| 60 | Global interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium from FIGO and allied partners: Information for healthcare professionals (guideline) Poon LC, Yang H, Kapur A, Melamed N, Dao B, Divakar H, David McIntyre H, Kihara AB, Ayres-de-Campos D, Ferrazzi EM, Carlo Di Renzo G, Hod MÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ Int J Gynaecol Obstet. 2020 Jun;149(3):273-286 |
| 61 | ISUOG Consensus Statement on organization of routine and specialist obstetric ultrasound services in the context of COVID-19. (opinion) Abu-Rustum RS, Akolekar R, Sotiriadis A, Salomon LJ, Da Silva Costa F, Wu Q, Frusca T, Bilardo CM, Prefumo F, Poon LC Ultrasound Obstet Gynecol. 2020 Jun;55(6):863-870 |
| 62 | Coronavirus disease 2019 (COVID-19) in pregnant women: A report based on 116 casesÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ Yan J, Guo J, Fan C, Juan J, Yu X, Li J, Feng L, Li C, Chen H, Qiao Y, Lei D, Wang C, Xiong G, Xiao F, He W, Pang Q, Hu X, Wang S, Chen D, Zhang Y, Poon LC, Yang HÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ Am J Obstet Gynecol. 2020 Apr 23;223(1):111.e1-111.e14 |
| 63 | Why we should not stop giving aspirin to pregnantwomen during the COVID-19 pandemic (Letters to editor) Kwiatkowski S, Borowski D, Kajdy A, Poon LC, Rokita W, Wielgos MÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ Ultrasound Obstet Gynecol. 2020 Jun;55(6):841-843 |
| 64 | Novel coronavirus infection and pregnancy Yang H, Wang C, Poon LC Ultrasound Obstet Gynecol. 2020 Apr;55(4):435-437 |
| 65 | ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals Poon LC, Yang H, Lee JCS, Copel JA, Leung TY, Zhang Y, Chen D, Prefumo F Ultrasound Obstet Gynecol. 2020 May;55(5):700-708 |
| 66 | Plasma DNA end motif profiling as a fragmentomic marker in cancer, pregnancy and Transplantation Jiang P, Sun K, Peng W, Cheng SH, Ni M, Yeung PC, Heung MMS, Xie T, Shang H, Zhou Z, Chan RWY, Wong J, Wong VWS, Poon LC, Leung TY, Lam WKJ, Chan JYK, Chan HLY, Chan KCA, Chiu RWK, Lo YMD Cancer Discov. 2020 May;10(5):664-673 |
| 67 | Does low-dose aspirin initiated before 11 weeksâÃÂàgestation reduce the rate of preeclampsia? Chaemsaithong P, Cuenca-Gomez D, Plana MN, Gil MM, Poon LC Am J Obstet Gynecol. 2020 May;222(5):437-450 |
| 68 | Prevention of Spontaneous Preterm Birth Appiah K, Chaemsaithong P, Poon LCÃÂÃÂ ÃÂÃÂ ÃÂÃÂ ÃÂÃÂ MIMS JPOG 2019 ; 45 (4); 169-176 |
| 69 | Placental microRNA dataset of monochorionic twin pregnancies with and without selective fetal growth restriction Meng M, Cheng YKK, Wu L, Chaemsaithong P, Leung MBW, Chim SSC, Sahota DS, Li W, Poon LC, Wang CC, Leung TY Data in Breif Volume 30, June 2020, 105403 |
| 70 | Whole genome miRNA profiling revealed miR-199a as potential placental pathogenesis of selective fetal growth restriction in monochorionic twin pregnancies Meng M, Cheng YKK, Wu L, Chaemsaithong P, Leung MBW, Chim SSC, Sahota DS, Li W, Poon LC, Wang CC, Leung TY Placenta Volume 92, March 2020, Pages 44-53 |
| 71 | The predictive value of cervical shear wave elastography in the outcome of labor induction Lu J, Cheng YKY, Ho SYS, Sahota DS, Hui LL, Poon LC, Leung TY Acta Obstet Gynecol Scand. 2020 Jan;99(1):59-68 |
| 72 | From first-trimester screening to risk stratification of evolving pre-eclampsia in second and third trimesters of pregnancy: comprehensive approach Poon LC, Galindo A, Surbek D, Chantraine F, Stepan H, Hyett J, Tan KH, Verlohren S Ultrasound Obstet Gynecol. 2020 Jan;55(1):5-12 |
| 73 | Reasons for accepting or declining participation in the ASPRE trial: A qualitative study with women at high-risk of preterm-PE NikÃÂÃÂeviÃÂàAV, Dodd Z, Prior J, OâÃÂÃÂGorman N, Poon LC, Nicolaides KH Prenat Diagn. 2019 Nov;39(12):1127-1135 |
| 74 | Erratum to "The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention" Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, McAuliffe F, da Silva Costa F, von Dadelszen P, McIntyre HD, Kihara AB, Di Renzo GC, Romero R, D'Alton M, Berghella V, Nicolaides KH, Hod M Int J Gynaecol Obstet. 2019 Sep;146(3):390-391 |
| 75 | The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. (FIGO COMMITTEE REPORT) Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, McAuliffe F, Costa FD, von Dadelszen P, McIntyre HD, Kihara AB, Di Renzo GC, Romero R, D'Alton M, Berghella V, Nicolaides KH, Hod M, Hod M Int J Gynaecol Obstet. 2019 May;145 Suppl 1:1-33 |
| 76 | FIGO (International Federation of Gynecology and Obstetrics) Postpregnancy Initiative: Long-term maternal implications of pregnancy complications-follow-up considerations. Sheiner E, Kapur A, Retnakaran R, Hadar E, Poon LC, Mclntyre HD, Divakar H, Staff AC, Narula J, Kihara AB, Hod M. Int J Gynaecol Obstet 2019 Sep;147:1-31 |
| 77 | Clinical evaluation of a first trimester pregnancy algorithm predicting the risk of small for gestational age neonates Graham K, Park F, McLennan A, Pelosi M, Williams P, Poon LC, Hyett J Aust N Z J Obstet Gynaecol. 2019 Oct;59(5):670-676 |
| 78 | Prenatal visualization of paraumbilical veins in fetus with intra-abdominal umbilical vein stricture and intrauterine growth restriction Chan YM, Law KM, Poon LC, Leung TY Ultrasound Obstet Gynecol. 2019 Nov;54(5):697-698 |
| 79 | Inter-manufacturer comparison of automated immunoassays for the measurement of soluble FMS-like tyrosine kinase-1 and placental growth factor Cheng YKY, Poon LC, Shennan A, Leung TY, Sahota DS Pregnancy Hypertens. 2019 Jul;17:165-171 |
| 80 | Maternal hemodynamics in screen-positive and screen-negative women of the ASPRE trial Ling HZ, Guy GP, Bisquera A, Poon LC, Nicolaides KH, Kametas NA Ultrasound Obstet Gynecol. 2019 Jul;54(1):51-57 |
| 81 | Reproductive outcomes after surgical treatment of asherman syndrome: A systematic review Guo EJ, Chung JPW, Poon LC, Li TC Best Pract Res Clin Obstet Gynaecol. 2019 Aug;59:98-114 |
| 82 | Transvaginal three-dimensional assessment of Sylvian fissures at 18-30 weeksâÃÂàgestation Poon LC, Sahota DS, Chaemsaithong P, Nakamura T, Machida M, Naruse K, Wah YM, Leung TY, Pooh RK Ultrasound Obstet Gynecol. 2019 Aug;54(2):190-198 |
| 83 | Increased Sylvian fissure angle as early sonographic sign of malformation of cortical development Pooh RK, Machida M, Nakamura T, Uenishi K, Chiyo H, Itoh K, Yoshimatsu J, Ueda H, Ogo K, Chaemsaithong P, Poon LC Ultrasound Obstet Gynecol. 2019 Aug;54(2):199-206 |
| 84 | Good clinical practice advice: First trimester screening and prevention of pre- eclampsia in singleton pregnancy FIGO Working Group on Good Clinical Practice in MaternalâÃÂÃÂFetal Medicine Poon LC Int J Gynaecol Obstet. 2019 Mar;144(3):325-329 |
| 85 | Do specific ultrasonography features identified at the time of early pregnancy loss predict fetal chromosomal abnormality?ÃÂÃÂ A systematic review and meta-analysis Huang J, Zhu W, Tang J, Saravelos SH, Poon LC, Li TC Genes Dis. 2019 Jun 6(2):129-137 |
| 86 | The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, McAuliffe F, Costa FD, von Dadelszen P, McIntyre HD, Kihara AB, Di Renzo GC, Romero R, D'Alton M, Berghella V, Nicolaides KH, Hod M, Hod M Int J Gynaecol Obstet. 2019 May;145 Suppl 1:1-33 |
| 87 | Screening and prevention of pre-eclampsia: a review Chaemsaithong P , Appiah EK , Sahota DS , Leung TY, Poon LC Hong Kong J Gynaecol Obstet Midwifery 2019;19(1):56-72 |
| 88 | Factors that affect ultrasound-determined labor progress in women undergoing induction of labor Chaemsaithong P, Kwan AHW, Tse WT, Lim WT, Chan WWY, Chong KC, Leung TY, Poon LC Am J Obstet Gynecol. 2019 Jun;220(6):592.e1-592.e15 |
| 89 | Pre-induction transperineal ultrasound assessment for the prediction of labor outcome Chan WWY, Chaemsaithong P, Lim WT, Tse WT, Kwan AHW, Leung TY, Sahota D, Poon LC Fetal Diagn Ther. 2019 Apr;45(4):256-267 |
| 90 | Impact of preimplantation genetic testing for aneuploidy on obstetrical practice Chan YM, Li TC, Poon LC Curr Opin Obstet Gynecol. 2019 Apr;31(2):127-131 |
| 91 | Body mass index at 11âÃÂÃÂ13 weeksâÃÂàgestation and pregnancy complications in a Southern Chinese population: a retrospective cohort study Chaemsaithong P, Leung TY, Sahota DS, Cheng YKY, Leung WC, Lo TK, Poon LC J Matern Fetal Neonatal Med. 2019 Jun;32(12):2056-2068 |
| 92 | Comment on "First Trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters, and angiogenic factors" Sahota DS, Poon LC Prenat Diagn. 2018 Oct;38(11):891, 1 page |
| 93 | Updates on Screening, Prevention, Treatment, and Genetic Markers for Preeclampsia Palomaki GE, Martin JN Jr, Karumanchi SA, Poon LC Clin Chem. 2018 Dec;64(12):1684-1689 |
| 94 | Objective assessment of the fetal facial profile at second and third trimester of pregnancy Lu J, Sahota DS, Poon LC, Ting YH, Cheng YKY, Wang Y, Leung TY Prenat Diagn. 2019 Jan;39(2):107-115 |
| 95 | The first-trimester of pregnancy - a window of opportunity for prediction and prevention of pregnancy complications and future lifeÃÂÃÂ ÃÂÃÂ Poon LC, McIntyre HD, Hyett JA, da Fonseca EB, Hod M Diabetes Res Clin Pract. 2018 Nov;145:20-30 |
| 96 | Maternal hemodynamics, fetal biometry and Doppler indices in pregnancies followed up for suspected fetal growth restriction Roberts LA, Ling HZ, Poon LC, Nicolaides KH, Kametas NA Ultrasound Obstet Gynecol. 2018 Oct;52(4):507-514 |
| 97 | Transverse technique: complementary approach to measurement of first-trimester uterine artery Doppler Drouin O, Johnson J, Metcalfe A, Huber J, Schwarzenberger J,ÃÂÃÂ Winters E, Stavness L, Chaemsaithong P, Tse AWT, Lu J, Lim WT, Leung TY, Bujold E, Sahota D, Poon LC Ultrasound Obstet Gynecol. 2018 Nov;52(5):639-647 |
| 98 | Prediction of labor outcome using serial transperineal ultrasound in the first stage of labor Chor CM, Poon LC, Leung TY J Matern Fetal Neonatal Med. 2019 Jan;32(1):31-37 |
| 99 | Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE Tan MY, Poon LC, Rolnik DL, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Greco E, Papaioannou G, Wright D, Nicolaides KH Ultrasound Obstet Gynecol. 2018 Jul;52(1):52-59 |
| 100 | Uterine artery pulsatility index in the first trimester: assessment of intersonographer and intersampling site measurement differences Chaemsaithong P, Ting YH, Cheng KYY, Poon LC, Leung TY, Sahota DS J Matern Fetal Neonatal Med. 2018 Sep;31(17):2276-2283 |
| 101 | ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm Poon LC, Rolnik DL, Tan MY, Delgado JL, Tsokaki T, Akolekar R, Singh M, Andrade W, Efeturk T, Jani JC, Plasencia W, Papaioannou G, Blazquez AR, Carbone IF, Wright D, Nicolaides KH Ultrasound Obstet Gynecol. 2018 Jun;51(6):738-742 |
| 102 | Effect of change in posture on maternal functional hemodynamics at 35âÃÂÃÂ37 weeksâÃÂàgestation Guy GP, Ling HZ, Machuca M, Poon LC, Nicolaides KH Ultrasound Obstet Gynecol. 2018 Mar;51(3):368-374 |
| 103 | Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia Wright D, Poon LC, Rolnik DL, Syngelaki A, Delgado JL, Vojtassakova D, de Alvarado M, Kapeti E, Rehal A, Pazos A, Carbone IF, Dutemeyer V, Plasencia W, Papantoniou N, Nicolaides KH Am J Obstet Gynecol. 2017 Dec;217(6):685.e1-685.e5 |
| 104 | Integrated Proteomic and Metabolomic prediction of Term Preeclampsia Bahado-Singh R, Poon LC, Yilmaz A, Syngelaki A, Turkoglu O, Kumar P, Kirma J, Allos M, Accurti V, Li J, Zhao P, Graham SF, Cool DR, Nicolaides K Sci Rep. 2017 Nov 23;7(1):16189 (Page 1-10) |
| 105 | Impact of aspirin on trophoblastic invasion in women with abnormal uterine artery Doppler at 11-14 weeks: a randomized controlled study . E. Scazzocchio, D. Oros, D. Diaz, J. C. Ramirez, M. Ricart, E. Meler, R. GonzÃÂález de AgÃÂüero, E. Gratacos and F. Figueras Poon LC Ultrasound Obstet Gynecol. 2017 Apr;49(4):433 |
| 106 | Protocol for measurement of mean arterial pressure at 10âÃÂÃÂ40 weeksâÃÂàgestation Roberts L, Chaemsaithong P, Sahota DS, Nicolaides KH, Poon LC Pregnancy Hypertens. 2017 Oct;10:155-160 |
| 107 | Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history Poon LC, Wright D, Rolnik DL, Syngelaki A, Delgado JL, Tsokaki T, Leipold G, Akolekar R, Shearing S, De Stefani L, Jani JC, Plasencia W, Evangelinakis N, Gonzalez-Vanegas O, Persico N, Nicolaides KH Am J Obstet Gynecol. 2017 Nov;217(5):585.e1-585.e5 |
| 108 | ASPRE trial: performance of screening for preterm pre-eclampsia Rolnik DL, Wright D, Poon LC, Syngelaki A, O'Gorman N, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tenenbaum-Gavish K, Nicolaides KH Ultrasound Obstet Gynecol 2017 Oct;50(4):492-495 |
| 109 | Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE). O'Gorman N, Wright D, Rolnik DL, Nicolaides KH, Poon LC BMJ Open. 2016 Jun 28;6(6):e011801. doi: 10.1136/bmjopen-2016-011801. |
| 110 | Protocol for the prospective validation study: 'Screening programme for pre-eclampsia' (SPREE) Tan MY, Koutoulas L, Wright D, Nicolaides KH, Poon LC Ultrasound Obstet Gynecol. 2017 Aug;50(2):175-179 |
| 111 | Metabolomic determination of pathogenesis of late-onset preeclampsia Bahado-Singh RO, Syngelaki A, Mandal R, Graham SF, Akolekar R, Han B, Bjondahl TC, Dong E, Bauer S, Alpay-Savasan Z, Turkoglu O, Ogunyemi D, Poon LC, Wishart DS, Nicolaides KH J Matern Fetal Neonatal Med. 2017 Mar;30(6):658-664 |
| 112 | Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tenenbaum-Gavish K, Meiri H, Gizurarson S, Maclagan K, Nicolaides KH N Engl J Med. 2017 Aug 17;377(7):613-622 |
| 113 | Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11âÃÂÃÂ13 weeks' gestation O'Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, Wright A, Akolekar R, Cicero S, Janga D, Jani J, Molina F S, Paco Matallana C, Papantoniou N, Persico N, Plasencia W, Singh M, Nicolaides K H Ultrasound Obstet Gynecol 2017 Jun;49(6):751-755 |
| 114 | Maternal cardiac function at 35-37 weeks' gestation: relationship with birth weight Guy G.P., Ling H.Z., Machuca M., Poon LC, Nicolaides K.H. Ultrasound Obstet Gynecol. 2017 Jan;49(1):67-72 |
| 115 | Maternal cardiac function at 35-37 weeksâÃÂàgestation: prediction of preeclampsia and gestational hypertension Guy GP, Ling HZ, Garcia P, Poon LC, Nicolaides KH Ultrasound in Obstetrics and Gynecology Jan 2017;49(1):61-66 |
| 116 | Maternal Cardiovascular Function at 35-37 Weeks' Gestation: Relation to Maternal Characteristics Guy GP, Ling HZ, Garcia P, Poon LC, Nicolaides KH Ultrasound in Obstetrics and Gynecology Jan 2017;49(1):39-45 |
| 117 | Birth weight in live births and stillbirths Poon LC, Tan MY, Yerlikaya G, Syngelaki A, Nicolaides KH Ultrasound Obstet Gynecol Nov 2016;48(5):602-606 |
| 118 | Metabolomic Determination of Pathogenesis of Late-onset Preeclampsia. Bahado-Singh RO, Syngelaki A, Mandal R, Akolekar R, Han B, Bjondahl TC, Dong E, Bauer S, Alpay-Savasan Z, Graham S, Turkoglu O, Ogunyemi D, Poon LC, Wishart DS, Nicolaides KH. Journal of Maternal Fetal and Neonatal Medicine 2016, J Matern Fetal Neonatal Med. 2016; 28: 1-7. |
| 119 | Risk of preterm birth following treatment for cervical disease: Stakeholder meeting summary. Sasieni P, Castanon A, Landy R, Kyrgiou M, Kitchener H, Quigley M, Poon LC, Shennan A, Paraskevaidis E, Hollingworth A, Soutter P, Freeman Wang T, Peebles D, Prendeville W, Patnick J. British J Obstet Gynaecol 2015; doi: 10.1111/1471-0528.13839. |
| 120 | Cervical Cerclage for Preterm Birth Prevention in Twin Gestations with Short Cervix: A Case-Control_ Study. Houlihan C, Poon LC, Ciarlo M, Kim E, Guzman ER, Nicolaides KH. Ultrasound Obstet Gynecol 2016, doi: 10.1002/uog.15918. |
| 121 | Cervical pessary for prevention of preterm birth in singleton pregnancies with short cervical length: a multicentre, randomized controlled trial. Nicolaides KH, Syngelaki A, Poon LC, Picciarelli G, Tul N, Zamprakou A, Skyfta E, Parra-Cordero M, Palma-Dias R, Rodriquez Calvo J. New England Journal of Medicine 2016; 374:1044-52. |
| 122 | Contingent Screening for Small by Weight for Gestational Age Neonates. Frick AP,ÃÂÃÂ NicolaidesÃÂÃÂ KH,ÃÂÃÂ PoonÃÂÃÂ LC. Pediatr Endocrinol Rev 2016;13:568-573. |
| 123 | The use of ultrasound and other markers for early detection of preeclampsia. O'Gorman N,ÃÂÃÂ NicolaidesÃÂÃÂ KH,ÃÂÃÂ PoonÃÂÃÂ LC. Womens Health (Lond Engl) 2016;12:199-207. |
| 124 | Clinical implementation of routine screening for fetal trisomies by the cell-free DNA test contingent on results from first-trimester combined test. Gil MM, Revello R, Poon LC, Akolekar R, Nicolaides KH. Ultrasound Obstet Gynecol 2016; 47:45-52. |
| 125 | Prediction of large for gestational age neonates: Screening by maternal factors and biomarkers in the three trimesters of pregnancy. Frick A, Syngelaki S, Zheng MM, Poon LC*, Nicolaides KH. Ultrasound in Obstet Gynecol 2016;47:332-339. |
| 126 | Current controversies in prenatal diagnosis 3: Is there still a Value in a Nuchal Translucency Screening Ultrasound in conjunction with Maternal Plasma Non-Invasive cell free DNA testing?âÃÂàWilson RD, Poon LC, and Ghidini A. Prenatal Diagnosis 2015; doi: 10.1002/pd.4719. [Epub ahead of print_] |
| 127 | First trimester prediction of HELLP Syndrome. Oliveira N, Poon LC, Nicolaides KH, Baschat AA. Prenatal diagnosis 2016; 36:29-33. |
| 128 | Clinical validation of the IONAÃÂî test for first-trimester detection of trisomy 21, 18 and 13. Poon LC, Dumidrascu-Diris D, Francisco C, Fantasia I, Nicolaides KH. Ultrasound Obstet Gynecol 2016; 47:184-187 |
| 129 | Cervical pessaries for prevention of preterm birth: a randomised controlled trial. Nicolaides KH, Syngelaki A, Poon LC, De Paco C, Plasencia W, Molina F, Picciarelli G, Tul N, Celik E, Lau TK, Conturso R. Am J Obstet Gynecol 2016, 214:3.e1-9 |
| 130 | The prediction of preterm birth in twin pregnancy: an individual patient level meta-analysis. Kindinger LM, Poon LC, Cacciatore S, MacIntyre, Fox NS, Schuit E, Mol B, Liem S, Lim A, Hermans F, Serra V, Perales A, Darzi A, Bennett P, Nicolaides KH, Teoh TG. British J Obstet Gynaecol 2016; 123:877-884. |
| 131 | Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeksâÃÂàgestation. OâÃÂÃÂGorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, Nicolaides KH. Am J Obstet Gynecol 2015, pii: S0002-9378(15)00900-X. doi: 10.1016/j.ajog.2015.08.034. [Epub ahead of print_] |
| 132 | Prediction of small for gestational age neonates: screening by biophysical and biochemical markers at 19-24 weeks. PoonÃÂÃÂ LC, Lesmes C, Gallo DM, Akolekar R,ÃÂÃÂ NicolaidesÃÂÃÂ KH. Ultrasound Obstet Gynecol. 2015 May 18. doi: 10.1002/uog.14904. [Epub ahead of print_] |
| 133 | Poon L. Re: Prediction of early- and late-onset pregnancy-induced hypertension using placental volume on three-dimensional ultrasound and uterine artery Doppler. T. Arakaki, J. Hasegawa, M. Nakamura, S. Hamada, M. Muramoto, H. Takita, K. Ichizuka and A. Sekizawa. Ultrasound Obstet Gynecol 2015; 45: 539-543. Ultrasound Obstet Gynecol 2015;45:513. |
| 134 | Prediction of small for gestational age neonates: Screening by maternal serum biochemical markers at 19-24 weeks. Lesmes C, Gallo DM, Gonzalez R,ÃÂÃÂ PoonÃÂÃÂ LC*,ÃÂÃÂ NicolaidesÃÂÃÂ KH. Ultrasound Obstet Gynecol. 2015 May 13. doi: 10.1002/uog.14899. [Epub ahead of print_] |
| 135 | Prediction of small-for-gestational-age neonates: maternal biochemical markers at 30-34 weeks. Bakalis S, Gallo DM, Mendez O,ÃÂÃÂ PoonÃÂÃÂ LC*,ÃÂÃÂ NicolaidesÃÂÃÂ KH. Ultrasound Obstet Gynecol 2015; 46: 208-215. |
| 136 | Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks. Bakalis S, Peeva G, Gonzalez R,ÃÂÃÂ PoonÃÂÃÂ LC*,ÃÂÃÂ NicolaidesÃÂÃÂ KH. Ultrasound Obstet Gynecol. 2015 Mar 31. doi: 10.1002/uog.14863. [Epub ahead of print_] |
| 137 | Prediction of small-for-gestational-age neonates: screening by placental growth factor and soluble fms-like tyrosine kinase-1 at 35-37 weeks. Fadigas C, Peeva G, Mendez O,ÃÂÃÂ PoonÃÂÃÂ LC*,ÃÂÃÂ NicolaidesÃÂÃÂ KH. Ultrasound Obstet Gynecol 2015; 46: 191-197. |
| 138 | Prediction of small for gestational age neonates: screening by uterine artery Doppler and mean arterial pressure at 19-24 weeks. Lesmes C, Gallo DM, Saiid Y,ÃÂÃÂ PoonÃÂÃÂ LC*,ÃÂÃÂ NicolaidesÃÂÃÂ KH. Ultrasound Obstet Gynecol. 2015 Mar 24. doi: 10.1002/uog.14855. [Epub ahead of print_] |
| 139 | Prediction of small-for-gestational-age neonates: screening by uterine artery Doppler and mean arterial pressure at 35-37 weeks. Fadigas C, Guerra L, Garcia-Tizon Larroca S,ÃÂÃÂ PoonÃÂÃÂ LC*,ÃÂÃÂ NicolaidesÃÂÃÂ KH. Ultrasound Obstet Gynecol 2015; 45: 715-721. |
| 140 | Umbilical and fetal middle cerebral artery Doppler at 35-37 weeks' gestation in the prediction of adverse perinatal outcome. Akolekar R, Syngelaki A, Gallo DM,ÃÂÃÂ PoonÃÂÃÂ LC,ÃÂÃÂ NicolaidesÃÂÃÂ KH. Ultrasound Obstet Gynecol 2015; 46: 82-92. |
| 141 | Prediction of small-for-gestational-age neonates: screening by fetal biometry at 35-37 weeks. Fadigas C, Saiid Y, Gonzalez R,ÃÂÃÂ PoonÃÂÃÂ LC*,ÃÂÃÂ NicolaidesÃÂÃÂ KH. Ultrasound Obstet Gynecol 2015; 45: 559-565. |
| 142 | Competing risks model in screening for preeclampsia by maternal characteristics and medical history. Wright D, Syngelaki A, Akolekar R,ÃÂÃÂ PoonÃÂÃÂ LC,ÃÂÃÂ NicolaidesÃÂÃÂ KH. Am J Obstet Gynecol 2015; 213: 62.e1-62.e10. |
| 143 | Prediction of small for gestational age neonates: screening by fetal biometry at 19-24 weeks. Lesmes C, Gallo D, Panaiotova J,ÃÂÃÂ PoonÃÂÃÂ LC*,ÃÂÃÂ NicolaidesÃÂÃÂ KH. Ultrasound Obstet Gynecol 2015; 46: 198-207. |
| 144 | Umbilical and fetal middle cerebral artery Doppler at 30-34 weeks' gestation in the prediction of adverse perinatal outcome. Bakalis S, Akolekar R, Gallo DM,ÃÂÃÂ PoonÃÂÃÂ LC*,ÃÂÃÂ NicolaidesÃÂÃÂ KH. Ultrasound Obstet Gynecol 2015; 45: 409-420. |
| 145 | Prediction of small for gestational age neonates: Screening by uterine artery Doppler and mean arterial pressure at 30-34 weeks. Bakalis S, Stoilov B, Akolekar R,ÃÂÃÂ PoonÃÂÃÂ LC*,ÃÂÃÂ NicolaidesÃÂÃÂ KH. Ultrasound Obstet Gynecol 2015; 45: 707-714. |
| 146 | Mean arterial pressure in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Wright A, Wright D, Ispas CA,ÃÂÃÂ PoonÃÂÃÂ LC,ÃÂÃÂ NicolaidesÃÂÃÂ KH. Ultrasound Obstet Gynecol 2015; 45: 698-706. |
| 147 | Prediction of small for gestational age neonates: screening by fetal biometry at 30-34 weeks. Bakalis S, Silva M, Akolekar R,ÃÂÃÂ PoonÃÂÃÂ LC*,ÃÂÃÂ NicolaidesÃÂÃÂ KH. Ultrasound Obstet Gynecol 2015; 45: 551-558. |
| 148 | UK NHS pilot study on cell-free DNA testing in screening for fetal trisomies: Factors affecting uptake. Gil MM, Giunta G, Macalli EA, Poon LC, Nicolaides KH. Ultrasound Obstet Gynecol 2015; 45: 67-73. |
| 149 | Fetal fraction in maternal plasma cell-free DNA in the prediction of spontaneous preterm delivery. Quezada MS, Francisco C, Dumitrascu-Biris D, Nicolaides KH, Poon LC*. Ultrasound Obstet Gynecol 2015; 45: 101-105. |
| 150 | Maternal plasma cell-free DNA in the prediction of preeclampsia. Rolnik DL, OâÃÂÃÂGorman N, Fiolna M, van den Boom D, Nicolaides KH, Poon LC*. Ultrasound Obstet Gynecol 2015; 45: 106-111. |
| 151 | Early prediction of preeclampsia. PoonÃÂÃÂ LC,ÃÂÃÂ NicolaidesÃÂÃÂ KH. Obstet Gynecol Int. 2014; 2014: 297397. |
| 152 | Management of hypertriglyceridaemia-induced acute pancreatitis in pregnancy. AminÃÂÃÂ T,ÃÂÃÂ PoonÃÂÃÂ L, Teoh T, Moorthy K, Robinson S. J Matern Fetal Neonatal Med. 2014 Jul 29:1-13. [Epub ahead of print_] |
| 153 | Maternal serum anti-MÃÂüllerian hormone at 11-13 weeks' gestation in the prediction of preeclampsia. Birdir C, Fryze J, Vasiliadis H, Nicolaides KH,ÃÂàPoon LC*. J Matern Fetal Neonatal Med 2015; 28: 954-958. |
| 154 | Competing risk model in screening for preeclampsia by mean arterial pressure and uterine artery pulsatility index at 30-33 weeks' gestation. Tayyar A, Garcia-Tizon Larroca S,ÃÂÃÂ Poon LC, Wright D, Nicolaides KH. Fetal Diagn Ther. 2014; 36: 18-27. |
| 155 | Demographic factors that can be used to predict early-onset pre-eclampsia. Leung C, Saaid R, Pedersen L, Park F, Poon L, Hyett J. J Matern Fetal Neonatal Med 2015; 28: 535-539. |
| 156 | First-trimester maternal factors and biomarker screening for preeclampsia. Poon LC, Nicolaides KH. Prenat Diagn 2014; 34: 618-627. |
| 157 | Successful induction of labor: prediction by pre-induction cervical length, angle of progression and cervical elastography. Pereira S, Frick AP, Poon LC, Zamprakou A, Nicolaides KH. Ultrasound Obstet Gynecol 2014; 44: 468-475. |
| 158 | Is High Fetal Nuchal Translucency Associated with Submicroscopic Chromosomal Abnormalities by Array CGH? Huang J, Poon LC, Akolekar R, Choy KW, Leung TY, Nicolaides KH. Ultrasound Obstet Gynecol 2014; 43: 620-624. |
| 159 | Competing risks model in screening for preeclampsia by biophysical and biochemical markers at 30-33 weeksâÃÂàgestation. Garcia-Tizon Larroca S, Tayyar A, Poon LC, Wright D, Nicolaides KH. Fetal Diagn Ther 2014; 36: 9-17. |
| 160 | Prediction of preeclampsia by mean arterial pressure at 11-13 and 20-24 weeksâÃÂàgestation. Gallo D, Poon LC, Fernandez M, Wright D, Nicolaides KH. Fetal Diagn Ther 2014; 36: 28-37. |
| 161 | Competing risks model in screening for preeclampsia by serum placental growth factor and soluble fms-like tyrosine kinase-1 at 30-33 weeksâÃÂàgestation. Lai J, Garcia-Tizon Larroca S, Peeva G, Poon LC, Wright D, Nicolaides KH. Fetal Diagn Ther 2014; 35: 240-248. |
| 162 | Optimal method and timing of intrauterine intervention in TRAP sequence: case study and meta-analysis. Chaveeva P, Poon LC, Sotiriadis A, Kosinski P, Nicolaides KH. Fetal Diagn Ther 2014; 35: 267-279. |
| 163 | Maternal serum placental growth factor (PlGF) isoforms 1 and 2 at 11-13, 20-24 and 30-34 weeksâÃÂàgestation in late onset preeclampsia and small for gestational age. Nucci M, Poon LC, Demirdjian G, Darbouret B, Nicolaides KH. Fetal Diagn Ther 2014; 35: 249-257. |
| 164 | Maternal serum placental growth factor (PlGF) isoforms 1 and 2 at 11-13 weeksâÃÂàgestation in preeclampsia and small for gestational age. Nucci M, Poon LC, Demirdjian G, Darbouret B, Nicolaides KH. Fetal Diagn Therr 2014; 35: 249-257. |
| 165 | Prediction of preeclampsia by uterine artery Doppler at 20-24 weeksâÃÂàgestation. Gallo D, Poon LC, Akolekar R, Syngelaki A, Nicolaides KH. Fetal Diagn Ther 2013; 1: 241-247. |
| 166 | Trichorionic and dichorionic triplet pregnancies at 10-14 weeks: Outcome after embryo reduction compared to expectant management. Chaveeva P, Kosinski P, Puglia D, Poon L, Nicolaides K. Fetal Diagn Ther 2013; 1: 199-205. |
| 167 | First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing. Nicolaides KH, Syngelaki A, Poon LC, Gil M, Wright D. Fetal Diagn Ther 2014; 35: 185-192. |
| 168 | Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy. Park FJ,ÃÂÃÂ Leung CH,ÃÂÃÂ PoonÃÂÃÂ LC,ÃÂÃÂ Williams PF,ÃÂÃÂ Rothwell SJ,ÃÂÃÂ HyettÃÂÃÂ JA. Aust N Z J Obstet GynaecolÃÂÃÂ 2013; 53: 532-539. |
| 169 | How feasible is expectant management of interstitial ectopic pregnancy? Poon LC, Emmanuel E, Ross J, Johns J. Ultrasound Obstet Gynecol 2013, Ultrasound Obstet Gynecol 2014; 43: 317-321. |
| 170 | Association of placental perfusion, as assessed by magnetic resonance imaging and uterine artery Doppler ultrasound, and its relationship to pregnancy outcome. Derwig I, Lythgoe DJ, Barker GJ, Poon L, Gowland P, Yeung R, Fernando Z, Nicolaides, KH. Placenta 2013; 34: 885-891. |
| 171 | First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell free DNA testing. Nicolaides KH, Wright D, Poon L,ÃÂÃÂ Syngelaki A, Gil M. Ultrasound Obstet Gynecol 2013; 42: 41-50. |
| 172 | Second-trimester screening for trisomy 21 using prefrontal space ratio. Chaveeva P, Agathokleous M, Poon LC, Markova D, Nicolaides KH. Fetal Diagn Ther 2013; 34: 50-55. |
| 173 | Maternal thyroid function at 11-13 weeksâÃÂàgestation in twin pregnancy. Ashoor G, Muto O, Poon LC, Abdulla M, Nicolaides KH. Thyroid 2013; 23: 1165-1171. |
| 174 | Maternal serum cytokines at 30-33 weeks in the prediction of preeclampsia. Mosimann B, Wagner M, Poon LC, Bansal AS, Nicolaides KH. Prenatal Diagnosis 2013; 33: 823-830. |
| 175 | Association of placental T2 relaxation times and uterine artery Doppler ultrasound measures of placental blood flow. Derwig I, Barker GJ, Poon L, Zelaya F, Gowland P, Lythgoe DJ, Nicolaides KH. Placenta 2013; 34: 474-479. |
| 176 | Natural killer cells and their activation status in normal pregnancy. Mosimann B, Wagner M, Shehata H, Poon LC, Ford B, Nicolaides KH, Bansal AS. International Journal of Reproductive Medicine 2013; 2013: 906813. |
| 177 | Maternal plasma cell-free fetal and maternal DNA at 11-13 weeksâÃÂàgestation: Relation to fetal and maternal characteristics and pregnancy outcomes. Poon LC, Musci T, Song K, Syngelaki A, Nicolaides KH. Fetal Diagn Ther 2013; 33: 215-223. |
| 178 | Maternal Serum Placental Growth Factor, Pregnancy-Associated Plasma Protein-A and Free ÃÂò-Human Chorionic Gonadotrophin at 30-33 Weeks in the Prediction of Pre-Eclampsia. LaiÃÂàJ, Pinas A, Poon LC, Agathokleous M,ÃÂàNicolaidesÃÂàKH. Fetal Diagn Ther 2013; 33: 164-172. |
| 179 | Meta-analysis of second-trimester markers for trisomy 21. Agathokleous M, Chaveeva P, Poon LC, Kosinski P, Nicolaides KH. Ultrasound Obstet Gynecol 2013; 41: 247-261. |
| 180 | Maternal serum tumour necrosis factor receptor 1 (TNF-R1) at 30-33 weeks in the prediction of preeclampsia. Mosimann B,ÃÂÃÂ Wagner M,ÃÂÃÂ Birdir C,ÃÂÃÂ PoonÃÂÃÂ LC,ÃÂÃÂ NicolaidesÃÂÃÂ KH. J Matern Fetal Neonatal MedÃÂÃÂ 2013; 26: 763-767. |
| 181 | Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics. Ashoor G, Syngelaki A,ÃÂÃÂ PoonÃÂÃÂ L, Rezende J,ÃÂÃÂ NicolaidesÃÂÃÂ K. Ultrasound Obstet Gynecol 2013; 41: 26-32. |
| 182 | Maternal serum retinol-binding protein-4 at 11-13 weeksâÃÂàgestation in normal and pathological pregnancies. Nanda S, Nikoletakis G, Markova D, Poon LC, Nicolaides KH. Metabolism 2013; 62: 814-819. |
| 183 | Maternal serum activin-A at 30-33 weeks in the prediction of preeclampsia. Lai J, Pinas A, Syngelaki A, Poon LC, Nicolaides KH. J Matern Fetal Neonatal Med 2013; 26: 733-737. |
| 184 | Mean arterial pressure, systolic and diastolic blood pressure at 30âÃÂÃÂ33 weeks in the prediction of preeclampsia. Lai J, Poon LC, Bakalis S, Markova D, Nicolaides KH. Fetal Diagn Ther 2013; 33: 173-181. |
| 185 | Uterine artery Doppler at 30âÃÂÃÂ33 weeksâÃÂàgestation in the prediction of preeclampsia. Lai J, Poon LC, Pinas A, Bakalis S, Nicolaides KH. Fetal Diagn Ther 2013; 33: 156-163. |
| 186 | Second-trimester uterine artery Doppler in the prediction of stillbirths. Poon LC, Volpe N, Muto B, Yu CKH, Syngelaki A, Nicolaides KH. Fetal Diagn Ther 2013; 33: 28-35. |
| 187 | Combined screening for preeclampsia and small for gestational age at 11âÃÂÃÂ13 weeks. Poon LC, Syngelaki A, Akolekar R, Lai J, Nicolaides KH. Fetal Diagn Ther 2013; 33: 16-27. |
| 188 | Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Akolekar R, Syngelaki A, Poon LC, Wright D, Nicolaides KH. Fetal Diagn Ther 2013; 33: 8-15. |
| 189 | Maternal serum soluble endoglin (sEng) at 30-33 weeks in the prediction of preeclampsia. Lai J, Syngelaki A, Poon LC, Nucci M, Nicolaides KH. Fetal Diagn Ther 2013; 33: 149-155. |
| 190 | A competing risks model in early screening for preeclampsia. Wright D, Akolekar R, Syngelaki A, Poon LC, Nicolaides KH. Fetal Diagn Ther 2012; 32: 171-178. |
| 191 | Birthweight with gestation and maternal characteristics in live births and stillbirths. Poon LC, Volpe N, Muto B, Syngelaki A, Nicolaides KH. Fetal Diagn Ther 2012; 32: 156-165. |
| 192 | C-reactive protein at 11 to 13 weeksâÃÂàgestation in spontaneous early preterm delivery. Bakalis S, Poon LC, Vayna AM, Pafilis I, Nicolaides KH. J Matern Fetal Neonatal Med 2012; 25: 2475-2478. |
| 193 | Maternal serum ferritin at 11 to 13 weeksâÃÂàgestation in spontaneous early preterm delivery. Beta J, Poon LC, Bakalis S, Mosimann B, Nicolaides KH. J Matern Fetal Neonatal Med 2012; 25:1852-1855. |
| 194 | Fetal fraction in maternal plasma cell-free DNA at 11-13 weeksâÃÂàgestation: Effect of maternal and fetal factors. Ashoor G, Poon LC, Syngelaki A, Mosimann B, Nicolaides KH. Fetal Diagn Ther 2012; 31: 237-243. |
| 195 | First trimester screening for spontaneous preterm delivery with maternal characteristics and cervical length. Greco E, Gupta R, Syngelaki A, Poon LC, Nicolaides KH. Fetal Diagn Ther 2012; 31: 154-161. |
| 196 | Protocol for measurement of mean arterial pressure at 11-13 weeksâÃÂàgestation. Poon LC, Zymeri NA, Zamprakou A, Syngelaki A, Nicolaides KH. Fetal Diagn Ther 2012; 31: 42-48. |
| 197 | First trimester screening for neural tube defects using AFP. Bredaki FE, Poon LC, Birdir C, Escalante D, Nicolaides KH. Fetal Diagn Ther 2012; 31: 109-114. |
| 198 | Maternal serum resistin at 11-13 weeksâÃÂàgestation in normal and pathological pregnancies. Nanda S, Poon LC, Muhaisen M, Acosta IC, Nicolaides KH. Metabolism 2012; 61: 699-705. |
| 199 | Large loop excision of transformation zone and cervical length in the prediction of spontaneous preterm delivery. Poon LC, Savvas M, Zamblera D, Skyfta E, Nicolaides KH. BJOG 2012; 119: 692-698. |
| 200 | Systolic diastolic and mean arterial pressure at 11-13 weeks in the prediction of hypertensive disorders in pregnancy: a prospective screening study. Poon LC, Kametas NA, Valencia C, Chelemen T, Nicolaides KH. Hypertens Pregnancy 2011; 30: 93-107. |
| 201 | First-trimester prediction of macrosomia. Poon LC, Karagiannis G, Stratieva V, Syngelaki A, Nicolaides KH. Fetal Diagn Ther 2011; 29: 139-147. |
| 202 | Reference range of birth weight with gestation and first-trimester prediction of small for gestation neonates. Poon LC, Karagiannis G, Staboulidou I, Shafiei A, Nicolaides KH. Prenat Diagn 2011; 31: 58-65. |
| 203 | Normal ranges of embryonic length, embryonic heart rate, gestational sac diameter and yolk sac diameter in early pregnancy. Papaioannou GKI, Syngelaki A, Poon LC, Ross J, Nicolaides KH. Fetal Diagn Ther 2010; 28: 207-219. |
| 204 | Hypertensive disorders in pregnancy: Screening by biophysical and biochemical markers at 11-13 weeks. Poon LC, Akolekar R, Lachmann R, Beta J, Nicolaides KH. Ultrasound in Obstetrics and Gynecology 2010; 35: 662-670. |
| 205 | Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11-13 weeks. Poon LC, Stratieva V, Piras S, Piri S, Nicolaides KH. Prenat Diagn 2010; 30: 216-223. |
| 206 | Hypertensive disorders in pregnancy: Screening by uterine artery Doppler and blood pressure at 11-13 weeks. Poon LC, Karagiannis G, Leal A, Romero Infante X, Nicolaides KH. Ultrasound in Obstetrics and Gynecology 2009; 34: 497-502. |
| 207 | Hypertensive disorders in pregnancy: Screening by uterine artery Doppler at 11-13 weeks. Poon LC, Staboulidou I, Maiz N, Plasencia W, Nicolaides KH. Ultrasound in Obstetrics and Gynecology 2009; 34: 142-148. |
| 208 | Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. Poon LC, Kametas NA, Chelemen T, Leal A, Nicolaides KH. J Hum Hypertens 2010; 24: 104-110. |
| 209 | First-trimester prediction of hypertensive disorders in pregnancy. Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. Hypertension 2009; 53: 812-818. |
| 210 | First-trimester maternal serum matrix metalloproteinase-9 (MMP-9) and adverse pregnancy outcome. Poon LC, Nekrasova E, Anastassopoulos P, Livanos P, Nicolaides KH. Prenatal Diagnosis 2009; 29: 553-559. |
| 211 | Maternal serum placental growth factor (plgf) at 11+0 to 13+6 weeks of gestation in small for gestational age pregnancy. Poon LC, Zaragoza E, Akolekar R, Anagnostopoulos E, Nicolaides KH. Prenatal Diagnosis 2008; 28: 1110-1115. |
| 212 | First trimester urinary placental growth factor and development of pre-eclampsia. Savvidou M, Akolekar R, Zaragoza E, Poon L, Nicolaides KH. BJOG 2009; 116: 643-647. |
| 213 | First-trimester maternal serum tumor necrosis factor receptor-1 (TNF-R1) and preeclampsia. Leal AM, Poon LC, Frisova V, Veduta A, Nicolaides KH. Ultrasound in Obstetrics and Gynecology 2009; 33: 135-141. |
| 214 | Maternal serum placental growth factor (plgf) at 11+0 to 13+6 weeks of gestation in hypertensive disorders of pregnancy. Akolekar R, Zaragoza E, Poon LC, Pepes S, Nicolaides KH. Ultrasound in Obstetrics and Gynecology 2008; 32: 732-739. |
| 215 | Maternal serum placental growth factor (plgf) at 11+0-13+6 weeks in chromosomally abnormal pregnancies. Zaragoza E, Akolekar R, Poon LC, Pepes S, Nicolaides KH. Ultrasound in Obstetrics and Gynecology 2009; 33: 382-386. |
| 216 | First-trimester maternal serum PAPP-A and preeclampsia. Poon LC, Maiz N, Valencia C, Plasencia W, Nicolaides KH. Ultrasound in Obstetrics and Gynecology 2009; 33: 23-33. |
| 217 | Maternal serum ADAM12 (A Disintegrin And Metalloprotease) in chromosomally abnormal pregnancies at 11+0-13+6 weeks. Poon LC, Chelemen T, Minekawa R, Frisova V, Nicolaides KH. American Journal Obstetrics and Gynecology 2009; 200: 508.e1-6. |
| 218 | First trimester maternal serum A Disintegrin And Metalloprotease 12 and adverse pregnancy outcome. Poon LC, Chelemen T, Granvillano O, Pandeva I, Nicolaides KH. Obstetric Gynecol 2008; 112: 1082-1090. |
| 219 | Fetal Medicine Foundation Prolonged Pregnancy Group. Cervical length and maternal factors in expectantly managed prolonged pregnancy: prediction of onset of labor and mode of delivery. Rao A, Celik E, Poggi S, Poon L, Nicolaides KH; Ultrasound Obstet Gynecol 2008; 32: 646-651. |
| 220 | Prediction of preeclampsia by a combination of maternal history, uterine artery doppler and mean arterial pressure. Onwudiwe N, Yu CKH, Poon LC, Spiliopoulos I, Nicolaides KH. Ultrasound Obstet Gynecol 2008; 32: 877-883. |
| 221 | Uterine artery Doppler at 11+0-13+6 weeks and 21+0-24+6 weeks in the prediction of pre-eclampsia. Plasencia W, Maiz N, Poon L, Yu C, Nicolaides KH. Ultrasound Obstet Gynecol 2008; 32: 138-146. |
| 222 | Inter-arm blood pressure differences in pregnant women. Poon LC, Kametas N, Strobl I, Pachoumi C, Nicolaides KH. BJOG 2008; 115: 1122-1130. |
| 223 | Mean arterial pressure at 11+0-13+6 weeks in the prediction of pre-eclampsia. Poon LC, Kametas N, Pandeva IV, Valencia CM, Nicolaides KH. Hypertension 2008; 51: 1027-1033. |
| 224 | Urine albumin concentration and albumin-to-creatinine ratio at 11+0-13+6 weeks in the prediction of pre-eclampsia. Poon LC, Kametas N, Bonino S, Vercellotti E, Nicolaides KH. BJOG 2008; 115: 866-873. |
| 225 | Blood pressure levels correlate with intra-individual variability using an automated device in early pregnancy. Poon LC, Kametas N, Valencia CM, Pandeva IV, Nicolaides KH. J Hum Hypertens 2008; 22: 438-440. |
| 226 | Tetralogy of Fallot in the fetus in the current era. Poon LC, Huggon I, Zidere V and Allan LD. Ultrasound Obstet Gynecol 2007; 29: 625-627. |
| 227 | Audit of the effectiveness of cervical preparation with Dilapan prior to late second trimester (20-24 weeks) surgical termination of pregnancy. Poon LC, Parsons J. BJOG 2007; 114: 485-488. |